BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38632185)

  • 1. Mechanistic correlation of molecular pathways in obesity-mediated stroke pathogenesis.
    Khan H; Tiwari C; Kalra P; Vyas D; Grewal AK; Singh TG
    Pharmacol Rep; 2024 Jun; 76(3):463-474. PubMed ID: 38632185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways in obesity: mechanisms and therapeutic interventions.
    Wen X; Zhang B; Wu B; Xiao H; Li Z; Li R; Xu X; Li T
    Signal Transduct Target Ther; 2022 Aug; 7(1):298. PubMed ID: 36031641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
    Goran MI; Alderete TL
    Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K signaling in the pathogenesis of obesity: The cause and the cure.
    Beretta M; Bauer M; Hirsch E
    Adv Biol Regul; 2015 May; 58():1-15. PubMed ID: 25512233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic signals and innate immune activation in obesity and exercise.
    Ringseis R; Eder K; Mooren FC; Krüger K
    Exerc Immunol Rev; 2015; 21():58-68. PubMed ID: 25825956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the effect of adipose tissue inflammation on insulin resistance.
    Yan K
    Cell Signal; 2024 Aug; 120():111229. PubMed ID: 38763181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
    Finelli C; Tarantino G
    World J Gastroenterol; 2013 Feb; 19(6):802-12. PubMed ID: 23430039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lymphatic Vasculature: Its Role in Adipose Metabolism and Obesity.
    Escobedo N; Oliver G
    Cell Metab; 2017 Oct; 26(4):598-609. PubMed ID: 28844882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
    Blüher M
    Clin Sci (Lond); 2016 Sep; 130(18):1603-14. PubMed ID: 27503945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review.
    Hamjane N; Benyahya F; Nourouti NG; Mechita MB; Barakat A
    Microvasc Res; 2020 Sep; 131():104023. PubMed ID: 32485192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
    Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
    PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights.
    Kalupahana NS; Claycombe KJ; Moustaid-Moussa N
    Adv Nutr; 2011 Jul; 2(4):304-16. PubMed ID: 22332072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of adipose tissue hypoxia in obesity and insulin resistance.
    Ye J
    Int J Obes (Lond); 2009 Jan; 33(1):54-66. PubMed ID: 19050672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Resistance, Obesity and Lipotoxicity.
    Yazıcı D; Sezer H
    Adv Exp Med Biol; 2017; 960():277-304. PubMed ID: 28585204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines: a link between obesity and cardiovascular disease.
    Nakamura K; Fuster JJ; Walsh K
    J Cardiol; 2014 Apr; 63(4):250-9. PubMed ID: 24355497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of local adipose tissue trace element homeostasis as a possible mechanism of obesity-related insulin resistance.
    Tinkov AA; Sinitskii AI; Popova EV; Nemereshina ON; Gatiatulina ER; Skalnaya MG; Skalny AV; Nikonorov AA
    Med Hypotheses; 2015 Sep; 85(3):343-7. PubMed ID: 26112161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in obesity: adiposity signaling and fat metabolism in energy homeostasis.
    Aja S; Moran TH
    Adv Psychosom Med; 2006; 27():1-23. PubMed ID: 16418539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.